Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Teeft.i » - entrée « Antiviral activity »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiviral activities < Antiviral activity < Antiviral agent  Facettes :

List of bibliographic references indexed by Antiviral activity

Number of relevant bibliographic references: 67.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000B09 (2012) Enguang Feng [République populaire de Chine] ; Deju Ye [République populaire de Chine] ; Jian Li [République populaire de Chine] ; Dengyou Zhang [République populaire de Chine] ; Jinfang Wang [République populaire de Chine] ; Fei Zhao [République populaire de Chine] ; Rolf Hilgenfeld [République populaire de Chine, Allemagne] ; Mingyue Zheng [République populaire de Chine] ; Hualiang Jiang [République populaire de Chine] ; Hong Liu [République populaire de Chine]Recent Advances in Neuraminidase Inhibitor Development as Anti‐influenza Drugs
001854 (2001) Michael G. Ison [États-Unis] ; Frederick G. Hayden [États-Unis]Therapeutic options for the management of influenza
001884 (2001) Alexander C. Schmidt [États-Unis] ; Robert B. Couch [États-Unis] ; George J. Galasso [États-Unis] ; Frederick G. Hayden [États-Unis] ; John Mills [Australie] ; Brian R. Murphy [États-Unis] ; Robert M. Chanock [États-Unis]Current research on respiratory viral infections: Third International Symposium
001913 (2000) D. L Suarez [États-Unis] ; S. Schultz-Cherry [États-Unis]Immunology of avian influenza virus: a review
001942 (2000) Margaret Tisdale [Royaume-Uni]Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors
001951 (2000) Robert W. Sidwell [États-Unis] ; Donald F. Smee [États-Unis]In vitro and in vivo assay systems for study of influenza virus inhibitors
001956 (2000) J. Yoshimoto [Japon] ; S. Yagi [Japon] ; J. Ono [Japon] ; K. Sugita [Japon] ; N. Hattori [Japon] ; T. Fujioka [Japon] ; T. Fujiwara [Japon] ; H. Sugimoto [Japon] ; N. Hashimoto [Japon]Development of Anti‐influenza Drugs: II. Improvement of Oral and Intranasal Absorption and the Anti‐influenza Activity of Stachyflin Derivatives
001963 (2000) Flor M. MunozAntiviral agents in the critically ill child
001A22 (1999) Andrzej Myc [États-Unis] ; Marie J. Anderson [États-Unis] ; James R. Baker Jr [États-Unis]Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents
001A29 (1999) Kazuya Mori [Japon] ; Toshitaka Kido [Japon] ; Haruyuki Daikuhara [Japon] ; Iwao Sakakibara [Japon] ; Toshiya Sakata [Japon] ; Keiko Shimizu [Japon] ; Sakae Amagaya [Japon] ; Hiroshi Sasaki [Japon] ; Yasuhiro Komatsu [Japon]Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus
001A32 (1999) Philip R. Wyde [États-Unis]Chemotherapy of respiratory viruses: prospects and challenges
001A46 (1998) John S. Oxford [Royaume-Uni] ; Robert Lambkin [Royaume-Uni]Targeting influenza virus neuraminidase—a new strategy for antiviral therapy
001A99 (1998) Spyroula S. Papakonstantinou-Garoufalia [Grèce] ; Ekaterini Tani [Grèce] ; Ourania Todoulou [Grèce] ; Aspasia Papadaki-Valiraki [Grèce] ; Evagelos Filippatos [Grèce] ; Erik De Clercq [Belgique] ; Panos N. Kourounakis [Grèce]Medicinal Chemistry: Synthesis and Pharmacochemical Investigation of Some Novel 1, 2, 4‐4H‐triazoles with Potential Antiviral Activity
001B00 (1998) Christoph Scholtissek [États-Unis] ; Robert G. Webster [États-Unis]Long-term stability of the anti-influenza A compounds—amantadine and rimantadine
001B03 (1998) Julia Serkedjieva [Bulgarie] ; Alan J. Hay [Royaume-Uni]In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L.
001B04 (1998) C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis]How to overcome resistance of influenza A viruses against adamantane derivatives
001B30 (1997) Richard L. HodinkaWHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCE
001B66 (1997) A. Z. Abyshev [Russie] ; A. T. Alekseev [Russie] ; V. G. Platonov [Russie] ; I. A. Byrkin [Russie]Synthesis and antiviral activity of benzopyran-2-one derivatives
001B76 (1997) K. Konno ; H. Inoue ; M. Fujiwara ; T. Mizuta ; H. Takayama ; Y. Iimura ; N. Aimi ; K. Tokuhisa ; Y. Hanasaki ; K. Katsuura ; S. Shigeta ; T. YokotaInhibitory effect of hirsutine on influenza virus replication in vitro
001B78 (1997) Kenji Sudo ; Wataru Watanabe ; Shinya Watanabe ; Ryu Sato ; Tsuyoshi Kajiyashiki ; Kenji Konno ; Shiro Shigeta ; Tomoyuki YokotaIn vitro and in vivo effects of RD3-0028 against respiratory syncytial virus
001B80 (1997) Edwin D. Kilbourne [États-Unis]In pursuit of influenza: Fort monmouth to valhalla (and back)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Antiviral activity" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Antiviral activity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Antiviral activity
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021